Status:
COMPLETED
Newborn Brain Test (NBT)
Lead Sponsor:
Professor Geraldine Boylan
Conditions:
Seizures Newborn
Brain Injuries
Eligibility:
All Genders
37-45 years
Brief Summary
The aim of the overall project is to develop the Newborn Brain Test (NBT), a novel platform to detect abnormal brain activity in infants at birth through an automated AI assessment. Easy to interpret ...
Detailed Description
EEG activity will be recorded using the standard CE marked portable EEG amplifier with four electrodes on the scalp. The test will be controlled using a tablet. The captured waveforms will be sent to ...
Eligibility Criteria
Inclusion
- All neonates≥ 37 and ≤45 weeks gestational age
- Parental informed consent
Exclusion
- Any Infant with head trauma or broken skin on the scalp
- Informed consent not obtained.
Key Trial Info
Start Date :
July 22 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 4 2025
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT06580834
Start Date
July 22 2024
End Date
February 4 2025
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cork University Maternity Hospital
Cork, Ireland, T12 YE02